Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial
Article in International Journal of Molecular Sciences (April 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Article in International Journal of Molecular Sciences (April 2024)
Article in International Journal of Rheumatic Diseases (April 2024)
Article in Inflammation Research (February 2024)